AM in the time of COVID-19AM IndustryDistribution

Stratasys will support Origin by delivering millions of 3D printed nasopharyngeal swabs

Reaching healthcare providers by leveraging its established distribution channels

Stay up to date with everything that is happening in the wonderful world of AM via our LinkedIn community.

In response to the pressing need for more COVID-19 testing, Stratasys, Inc. and high-speed layerless stereolithography 3D printer manufacturer Origin have signed an agreement in which Stratasys will market and promote Origin 3D printed nasopharyngeal swabs to healthcare providers and other testing centers in the U.S.

As widely reported, widespread testing of millions of people is currently hampered by a shortage of testing supplies. High-speed stereolithography 3D printers such as those from Carbon but also low-cost ones from Formlabs have proven capable of mass-producing nasal swabs (as have some laser sintering systems). Each Origin One 3D printer has shown it has the ability to produce batches of 1,500 Origin NP O1 Swabs at a time, multiple times daily. Origin is moving towards a streamlined process allowing the production of approximately 190,000 per day, or 1.3 million per week.

Stratasys will leverage its position as a leading provider of 3D printing solutions to the healthcare industry to market Origin NP O1 Swabs. Stratasys has already been actively serving healthcare systems across the country during the pandemic by leading a coalition that has been providing 3D-printed face shields to nearly 100 front-line organizations. To date, the coalition has provided about 40,000 shields at no cost to health systems.

3D printed nasopharyngeal swabs

“We have tremendous confidence in Origin’s 3D printing technology, and we’re confident in our ability to help bring them to market efficiently,” said Stratasys Americas President Rich Garrity adding that Stratasys is ready to help get millions of swabs to wherever they are most needed.

“We believe widespread testing can help save lives and get our economy going again, and we’re confident that our Origin One technology and simple material requirements will be able to produce millions of swabs to meet the need,” said Origin CEO, Christopher Prucha “We’ve been impressed by the speed with which Stratasys has been able to provide thousands of shields to healthcare systems across the country and believe they are the right partner for helping get millions of swabs where they are most needed.”

Origin swabs were tested in a clinical trial with Beth Israel Deaconess Medical Center, an academic medical center affiliated with Harvard Medical School. Origin reports that results show  Origin swabs performed the highest with regard to concordance to control swabs compared to two other 3D printed swabs. In addition, in subjective feedback, Origin swabs were preferred over the other 3D printed swabs.

Each Origin NP O1 Swab is autoclavable and individually packaged.

Research 2021
Metal AM Market Opportunities and Trends

This market study from 3dpbm Research provides an in-depth analysis and forecast of the three core segments...

Davide Sher

Since 2002, Davide has built up extensive experience as a technology journalist, market analyst and consultant for the additive manufacturing industry. Born in Milan, Italy, he spent 12 years in the United States, where he completed his studies at SUNY USB. As a journalist covering the tech and videogame industry for over 10 years, he began covering the AM industry in 2013, first as an international journalist and subsequently as a market analyst, focusing on the additive manufacturing industry and relative vertical markets. In 2016 he co-founded London-based 3dpbm. Today the company publishes the leading news and insights websites 3D Printing Media Network and Replicatore, as well as 3D Printing Business Directory, the largest global directory of companies in the additive manufacturing industry.

Related Articles

Back to top button

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • PHPSESSID
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services

STAY AHEAD

OF THE CURVE

Join industry leaders and receive the latest insights on what really matters in AM!

This information will never be shared with 3rd parties

I’ve read and accept the privacy policy.*

WELCOME ON BOARD!